25-011
Tohid Didar Zeinab Hosseinidoust Amid Shakeri Lubna Najm
US Provisional Patent Application Filed
Proof of principle data available
Amy Hector Business Development Manager
Immunofluorescence assays are crucial in the diagnosis of complex diseases via disease-associated biomarker detection. Unfortunately, most assays rely on two-dimensional microarrays that suffer from low repeatability and sensitivity, challenging their ability to monitor clinical disease progression. While there are three-dimensional microarrays with enhanced biorecognition capabilities, their component materials are not compatible with current microarray fabrication protocols.
Researchers at McMaster University have developed a platform for bioprinting three-dimensional microarrays that have ultra-high detection specificity and sensitivity and can be adopted for a wide range of diseases of interest, biosensor types, and biorecognition elements [1]. These immunosorbent hydrogels have been comprehensively optimized and assessed for enhanced diagnosis of bacterial-induced infection and sepsis. Given their ease of implementation, high-throughput fabrication, and ultrasensitive detection, these three-dimensional microarrays will enable better clinical monitoring of disease progression, yielding improved patient outcomes.